Pacer Advisors
EPZM

Pacer Advisors’s Epizyme, Inc EPZM Stock Holding History

Pacer Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,390
Closed -$56K – 1601
2021
Q1 		$56K Buy
6,390
+882
+16% +$9.13K ﹤0.01% 1430
2020
Q4 		$60K Buy
5,508
+1,409
+34% +$17.4K ﹤0.01% 1402
2020
Q3 		$49K Buy
+4,099
New +$54.9K ﹤0.01% 1306
2018
Q4 		– Sell
-4,441
Closed -$47K – 1117
2018
Q3 		$47K Buy
+4,441
New +$50.7K ﹤0.01% 1145
2018
Q1 		– Sell
-1,100
Closed -$14K – 1152
2017
Q4 		$14K Buy
+1,100
New +$16K ﹤0.01% 1125

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return